SCHEMBL5867470

SCHEMBL5867470

CCN(CC)CCNCc1ccc(-c2ccc(OC)c(F)c2F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ CHRM2 P08172 1/20 0.40
▸ HTR2A P28223 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ POLB P06746 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ S1PR1 P21453 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ PDCD1LG2 Q9BQ51 1/20 0.36
▸ CD274 Q9NZQ7 1/20 0.36
▸ P4HB P07237 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TMEM97 Q5BJF2 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313158 0.81 SMN1; SMN2 (0.41) SMN1; SMN2CHRM2HTR2AKDM4EKMT2A
SCHEMBL3537091 0.78 CD274 (0.41) SMN1; SMN2KDM4EKMT2AMEN1LMNA
SCHEMBL16803342 0.75 TUBB1 (0.38) —
SCHEMBL17614855 0.74 CYP17A1 (0.40) —
SCHEMBL17616201 0.73 GABRA1 (0.46) —
SCHEMBL3457044 0.72 HRH3 (0.51) SMN1; SMN2KMT2AMEN1LMNAALDH1A1
SCHEMBL20015622 0.72 TTR (0.41) KDM4EALDH1A1HTT
SCHEMBL20346164 0.72 CYP19A1 (0.38) —
SCHEMBL20429678 0.72 GABRA1 (0.45) —
SCHEMBL17616200 0.72 GABRA1 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115616-B2 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2006-10-03 — — US disclosed
US-6953803-B1 1-[(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)]-2-(4-fluorobenzyl)thio-5-(1-methyl-4-pyrazolylmethyl)pyrimidin-4-one; enzyme inhibitors of lipoprotein associated phospholipase A2 (Lp-PLA2); atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2005-10-11 — — US disclosed
Send feedback